Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
7.36
0.00 (0.00%)
At close: Feb 2, 2026, 4:00 PM EST
7.57
+0.21 (2.82%)
After-hours: Feb 2, 2026, 7:40 PM EST
Xeris Biopharma Holdings Market Cap
Xeris Biopharma Holdings has a market cap or net worth of $1.22 billion as of February 2, 2026. Its market cap has increased by 152.82% in one year.
Market Cap
1.22B
Enterprise Value
1.39B
1-Year Change
152.82%
Ranking
Category
Stock Price
$7.36
Market Cap Chart
Since October 6, 2021, Xeris Biopharma Holdings's market cap has increased from $295.78M to $1.22B, an increase of 312.88%. That is a compound annual growth rate of 38.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.22B | -6.24% |
| Dec 31, 2025 | 1.30B | 157.72% |
| Dec 31, 2024 | 505.39M | 55.70% |
| Dec 29, 2023 | 324.59M | 79.47% |
| Dec 30, 2022 | 180.86M | -50.50% |
| Dec 31, 2021 | 365.40M | 23.54% |
| Oct 6, 2021 | 295.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Relay Therapeutics | 1.33B |
| AnaptysBio | 1.31B |
| Savara | 1.30B |
| Immatics | 1.28B |
| Rapport Therapeutics | 1.27B |
| Taysha Gene Therapies | 1.24B |
| Sana Biotechnology | 1.18B |
| Day One Biopharmaceuticals | 1.15B |